Cargando…
Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles
Cisplatin is a first-line clinical agent used for treating solid tumors. Cisplatin damages the DNA of tumor cells and induces the production of high levels of reactive oxygen species to achieve tumor killing. Tumor cells have evolved several ways to tolerate this damage. Extracellular vesicles (EVs)...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418773/ https://www.ncbi.nlm.nih.gov/pubmed/37569723 http://dx.doi.org/10.3390/ijms241512347 |